PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636 | -25.5% | 242 | 0.0% | 0.00% | – |
| Q2 2023 | $854 | +14.2% | 242 | 0.0% | 0.00% | – |
| Q1 2023 | $748 | -27.0% | 242 | 0.0% | 0.00% | – |
| Q4 2022 | $1,024 | -100.0% | 242 | -98.8% | 0.00% | – |
| Q3 2022 | $47,206,000 | +20.8% | 19,918 | +45.3% | 0.00% | – |
| Q2 2022 | $39,062,000 | +19.6% | 13,706 | +20.9% | 0.00% | – |
| Q1 2022 | $32,651,000 | -5.4% | 11,337 | -0.1% | 0.00% | – |
| Q4 2021 | $34,516,000 | -28.7% | 11,354 | +64.4% | 0.00% | – |
| Q3 2021 | $48,418,000 | +302.9% | 6,907 | +427.7% | 0.00% | – |
| Q2 2021 | $12,017,000 | -83.8% | 1,309 | -82.8% | 0.00% | – |
| Q1 2021 | $74,037,000 | -94.5% | 7,617 | -94.2% | 0.00% | -100.0% |
| Q4 2020 | $1,342,521,000 | +1673.8% | 130,850 | +1644.4% | 0.00% | – |
| Q3 2020 | $75,685,000 | -23.7% | 7,501 | -21.1% | 0.00% | – |
| Q2 2020 | $99,148,000 | -68.6% | 9,506 | -74.6% | 0.00% | -100.0% |
| Q1 2020 | $315,783,000 | +744.4% | 37,415 | +775.4% | 0.00% | – |
| Q4 2019 | $37,398,000 | -79.0% | 4,274 | -74.2% | 0.00% | – |
| Q3 2019 | $178,258,000 | -18.5% | 16,559 | -3.7% | 0.00% | – |
| Q2 2019 | $218,625,000 | -48.7% | 17,201 | +56.6% | 0.00% | -100.0% |
| Q1 2019 | $426,186,000 | +319.6% | 10,987 | +120.1% | 0.00% | – |
| Q4 2018 | $101,567,000 | -40.0% | 4,991 | +35.1% | 0.00% | – |
| Q3 2018 | $169,416,000 | -13.4% | 3,695 | +11.7% | 0.00% | – |
| Q2 2018 | $195,727,000 | -97.1% | 3,309 | -96.7% | 0.00% | -100.0% |
| Q1 2018 | $6,804,660,000 | +1043.1% | 99,995 | +1560.5% | 0.01% | +1200.0% |
| Q4 2017 | $595,275,000 | +37.9% | 6,022 | +67.0% | 0.00% | 0.0% |
| Q3 2017 | $431,699,000 | +39.5% | 3,605 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $309,483,000 | -63.9% | 3,541 | -84.7% | 0.00% | -50.0% |
| Q1 2017 | $858,241,000 | +1231.9% | 23,071 | +999.1% | 0.00% | – |
| Q4 2016 | $64,439,000 | -54.9% | 2,099 | -1.6% | 0.00% | -100.0% |
| Q3 2016 | $143,018,000 | +377.2% | 2,133 | +112.0% | 0.00% | – |
| Q2 2016 | $29,969,000 | +164.3% | 1,006 | +160.6% | 0.00% | – |
| Q1 2016 | $11,337,000 | -81.1% | 386 | -49.5% | 0.00% | – |
| Q4 2015 | $59,898,000 | -97.5% | 764 | -97.6% | 0.00% | -100.0% |
| Q3 2015 | $2,396,825,000 | +1022.4% | 31,805 | +1638.9% | 0.01% | +500.0% |
| Q2 2015 | $213,536,000 | +63.8% | 1,829 | +231.3% | 0.00% | – |
| Q1 2015 | $130,333,000 | -59.8% | 552 | -59.4% | 0.00% | – |
| Q3 2014 | $324,217,000 | +6629.3% | 1,359 | +1761.6% | 0.00% | – |
| Q2 2014 | $4,818,000 | -83.7% | 73 | -74.5% | 0.00% | – |
| Q4 2013 | $29,610,000 | -90.8% | 286 | -95.2% | 0.00% | – |
| Q3 2013 | $321,638,000 | -18.2% | 5,994 | -32.3% | 0.00% | – |
| Q2 2013 | $393,029,000 | – | 8,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |